Complete Science-Backed Guide to Melasma: Causes, Hormonal Triggers & Real Fixes

That brownish-gray patch spreading across your cheeks isn’t going anywhere. Not with your $80 vitamin C serum. Not with a stronger exfoliant. Not even with the sunscreen you swear you apply every morning. If you’ve been fighting the same stubborn discoloration for months, or years, you’re dealing with something more complex than an ordinary sunspot.

You’re likely dealing with melasma, a chronic pigmentation disorder that affects an estimated 5 to 6 million women in the United States alone — a figure researchers themselves flag as likely an undercount, since it doesn’t capture people who go undiagnosed or never seek treatment for it (Clinical Advisor).

It shows up as symmetrical, brownish patches, usually across the cheeks, forehead, upper lip, or chin, and it has a frustrating habit of fading and then returning, often at the worst possible moment: after a beach vacation, a hormonal shift, or a stressful few months.

This guide breaks down what current dermatology research actually says about melasma. We’ll walk through what’s happening at the cellular level, why hormones like estrogen, progesterone, and thyroid hormone play such an outsized role, how everyday light exposure keeps the cycle going, and what an evidence-based treatment plan looks like in 2026.

No miracle claims. Just the science, explained clearly, and a realistic framework for managing it.

What Is Melasma? Understanding Epidermal, Dermal, and Mixed Types

Melasma is a chronic, acquired pigmentation condition that causes symmetrical, irregular brown-to-gray-brown patches, most commonly on sun-exposed areas of the face. Unlike a sunburn or an isolated dark spot, melasma tends to appear in a mirrored pattern on both sides of the face, and it’s classified as a disorder of melanocyte activity rather than simple sun damage.

Melasma vs. Hyperpigmentation vs. Sunspots — What’s the Difference?

The terms get used interchangeably, but they describe different things. Sunspots, also called solar lentigines, are discrete, localized dark spots caused by cumulative UV exposure. Post-inflammatory hyperpigmentation develops after an injury or inflammatory event, like acne or a cut, and typically fades on its own over months. Melasma is distinct: it’s driven primarily by hormonal influences interacting with light exposure, it appears in larger, more diffuse patches rather than discrete spots, and it’s notably more persistent and prone to recurrence than either of the other two.

For a closer look at how these pigmentation types differ and which fading strategies work for each, read our complete Acne Scars vs. Post-Inflammatory Hyperpigmentation guide.

The Three Clinical Patterns: Centrofacial, Malar, and Mandibular

Dermatologists classify melasma by where it appears on the face. The centrofacial pattern, the most common presentation, involves the forehead, cheeks, upper lip, nose, and chin. The malar pattern is limited to the cheeks and nose. The mandibular pattern, which is less common, affects the jawline. Recognizing which pattern you have can help a dermatologist tailor a treatment approach, since distribution sometimes correlates with different underlying triggers.

Epidermal, Dermal, and Mixed Melasma — Why the Old Wood’s Lamp Classification Is Losing Favor

For decades, dermatologists used a Wood’s lamp, a handheld device that emits UV-A light, to classify melasma as epidermal (pigment sitting in the upper skin layer), dermal (pigment deeper in the dermis), or mixed. In theory, epidermal melasma responds better to topical treatment, while dermal melasma is more treatment-resistant.

In practice, this classification system has proven unreliable. According to a clinical review published on the NIH’s StatPearls platform, Wood’s lamp findings are inconsistent, particularly in people with darker skin phototypes, and current literature indicates the results should not be used to guide prognosis or treatment decisions.

Newer research using dermoscopy has shown similar limitations, with different diagnostic tools frequently disagreeing on the same patient. Most dermatologists today rely on clinical evaluation rather than a single imaging tool.

Who Gets Melasma? (Skin Tone, Ethnicity, and Genetic Predisposition)

Melasma disproportionately affects women, particularly those with medium-to-deep skin tones, including Hispanic people, Latina, Asian, Middle Eastern, and North African. It’s also strongly associated with a family history of the condition, suggesting a genetic component layered on top of hormonal and environmental triggers. It can occur in men, though far less frequently, and when it does, the same hormonal and light-based mechanisms are typically involved.

Is Melasma the Same as Chloasma or “Pregnancy Mask”?

Chloasma and melasma refer to the same condition. Chloasma is the older term, derived from Greek, historically used specifically for cases that develop during pregnancy, sometimes called the “mask of pregnancy.” Today, most dermatology sources use “melasma” as the umbrella term regardless of the trigger, since the underlying biology is the same whether it appears during pregnancy, with hormonal birth control, or independent of any hormonal event.

The Root Drivers — Melanocyte Hyperactivity and the Vascular Connection

Understanding melasma requires looking past the surface. What you see on your skin is the result of a cascade of cellular changes that researchers are still working to fully map.

What Actually Happens Inside Melasma-Affected Skin

Melasma isn’t simply “too much sun.” A comprehensive review published in PMC describes it as a condition involving melanocyte hyperactivity, vascular changes, impaired skin barrier function, and dermal inflammation working together, rather than any single isolated cause. This is part of why melasma has historically been so difficult to treat with one product or one mechanism of action.

Melanocyte Hyperactivity: Why Some Cells Overproduce Pigment

Melanocytes are the pigment-producing cells in your skin. In melasma-affected skin, these cells become hyperfunctional, meaning they produce significantly more melanin than surrounding, unaffected skin, even though the actual number of melanocytes may not increase dramatically.

Multiple biological signals, including hormone receptors, growth factors, and inflammatory mediators, converge on these cells and push them into overdrive. This is why melasma can look deceptively similar to a tan but behaves in a fundamentally different, more stubborn way.

The Overlooked Vascular Component — Blood Vessels and VEGF

One of the more significant developments in melasma research over the past two decades involves blood vessels. Studies have found that melasma lesions contain a noticeably higher density of dermal blood vessels compared to unaffected skin nearby.

A widely cited study on the vascular characteristics of melasma found that factor VIIIa-related antigen staining showed an approximately 68.75% increase in the number and size of dermal vessels in lesional skin compared with surrounding skin, and that vascular endothelial growth factor, or VEGF, a signaling protein that promotes blood vessel growth, is elevated in these areas.

This matters because VEGF doesn’t just build blood vessels. It also appears to stimulate melanocyte activity directly, creating a feedback loop where increased vascularity and increased pigmentation reinforce one another. This is part of why some newer research and clinical treatments, including certain formulations of tranexamic acid, target vascular pathways in addition to pigment production.

Inflammation, Mast Cells, and a “Leaky” Basement Membrane

Melasma-affected skin also shows signs of low-grade, chronic inflammation. Researchers have documented increased mast cell activity, disruption of the basement membrane (the structural layer separating the epidermis from the dermis), and signs of oxidative stress in lesional skin.

A histopathology review in the Journal of Investigative Dermatology‘s affiliated literature describes melasma as behaving less like an isolated pigment problem and more like a chronic inflammatory disorder of the skin’s microenvironment. This broader understanding is shifting how researchers approach new treatments, moving beyond pigment-blocking ingredients alone toward strategies that also calm inflammation and vascular activity.

Why Does Melasma Keep Coming Back After Treatment?

This is the question that frustrates patients most, and the biology explains it well. Because the underlying vascular changes, inflammatory signaling, and hyperactive melanocytes don’t fully reverse with topical treatment alone, the skin remains primed to re-pigment when it’s exposed to another trigger, whether that’s sun exposure, a hormonal shift, or heat. This is why dermatologists emphasize long-term maintenance rather than a fixed “treatment and done” timeline.

The Hormonal Matrix — Estrogen, Progesterone, Thyroid, and Cortisol

If there’s one thing that sets melasma apart from most other pigmentation concerns, it’s how closely it’s tied to hormonal activity.

If you’re curious how hormonal fluctuation affects skin more broadly, our guide on What Causes Hormonal Acne? breaks down a related hormonal skin condition in more detail.

This section covers what the research actually shows, without overstating the certainty of the science.

Estrogen’s Role — Why Pregnancy and Birth Control Trigger Flare-Ups

Estrogen is the hormone most consistently linked to melasma onset. During pregnancy, estrogen, progesterone, and melanocyte-stimulating hormone all rise substantially, and according to background research summarized by Medscape, roughly half of all melasma cases initially present during pregnancy. A separate clinical epidemiology overview notes that melasma affects an estimated 15% to 50% of pregnant people, depending on the population studied.

For a deeper look at one of the pregnancy-safe standouts, see Azelaic Acid for Melasma During Pregnancy.

Oral contraceptives tell a similar story. Estimates on how many women who take estrogen-containing birth control develop melasma range from roughly 10% to 29%, based on different clinical studies, including a frequently cited JAMA investigation that found melasma developed in 61 of 212 patients, or 29%, taking oral contraceptives, as a direct result of the medication.

Notably, that same research found the pigmentation didn’t fully resolve after stopping the medication in every case, which reinforces why prevention and early intervention matter more than waiting to “see if it fades.”

Progesterone — The Hormone That May Matter Even More Than Estrogen

Progesterone’s role has become increasingly interesting to researchers. Laboratory studies looking at melanocyte behavior found that 17β-estradiol, a form of estrogen, stimulated melanocyte proliferation, while the effects of progesterone on pigmentation appeared more complex and varied between different progestogen types.

Clinically, an observation that’s often cited in dermatology literature is telling: postmenopausal women given progesterone alone tend to develop melasma, while those given estrogen alone typically do not. This has led some researchers to suspect progesterone may be a more direct driver of melasma than previously assumed, though the full mechanism is still being studied.

Thyroid Dysfunction and Melasma — What the Research Actually Shows

The connection between thyroid health and melasma is one of the more surprising findings in the research, and it dates back decades. An early study published in the Journal of Clinical Endocrinology & Metabolism was among the first to document evidence of an association between autoimmune thyroid disorders and melasma.

More recent research has reinforced this: a comparative study in the Journal of Cosmetic Dermatology found that women with melasma had an 18.5% frequency of thyroid disorders compared with just 4.3% among controls without melasma, a statistically significant difference.

Importantly, this is an association, not proof that thyroid dysfunction directly causes melasma in every patient. Researchers still don’t fully understand the mechanism. But if you have persistent melasma that isn’t responding to standard treatment, it’s reasonable to ask your physician about screening for thyroid dysfunction, particularly hypothyroidism, as part of ruling out contributing factors.

Cortisol and Chronic Stress: An Emerging (and Underrated) Trigger

Compared to estrogen, progesterone, and thyroid hormone, cortisol’s role in melasma has far less direct clinical research behind it. What’s known is that cortisol, the body’s primary stress hormone, interacts with the same endocrine pathways implicated in melasma, and chronic stress is broadly associated with disruptions in skin barrier function and inflammatory signaling.

Many dermatologists observe stress as an anecdotal trigger reported by patients, but current research is limited compared to the well-established roles of estrogen and progesterone. It’s a reasonable factor to monitor and manage as part of overall skin health, without expecting it to be a primary lever for melasma control on its own.

To understand how stress hormones influence skin conditions more broadly, read our guide on How Stress Affects Pre-Existing Skin Conditions.

Can Hormonal Birth Control Cause Melasma to Return?

Yes. If melasma developed or worsened during a previous course of hormonal birth control, restarting a similar formulation carries a meaningful risk of recurrence. This is worth discussing with both a prescribing physician and a dermatologist, since non-hormonal contraceptive options may be worth considering for patients with a history of melasma.

Does Menopause Make Melasma Better or Worse?

The research here is mixed. Some women notice improvement as estrogen and progesterone levels decline naturally. Others, particularly those started on hormone replacement therapy that includes progesterone, may see melasma persist or worsen. This variability is part of why hormonal management for melasma needs to be individualized rather than following a one-size-fits-all timeline.

Environmental Triggers — UV Rays, HEV Blue Light, and Heat

Hormones may load the gun, but light and heat exposure are what consistently pull the trigger. This is also the category where daily habits make the biggest measurable difference.

UV Radiation: The Trigger You Already Knew About

Ultraviolet radiation, particularly UVB, is a well-established driver of melasma. UV exposure directly stimulates melanocyte-specific genes and triggers the release of signaling molecules involved in melanin production. This is precisely why melasma so often worsens in summer months and why dermatologists consistently emphasize sun protection as the foundation of any treatment plan, not an optional add-on.

For context on how sunscreen formulation is evolving, see What the FDA’s First New UV Filter in 20 Years Means for Your Skin.

HEV Blue Light — From the Sun and Your Screens

High-energy visible (HEV) light, sometimes called blue light, sits just outside the UV spectrum on the light spectrum and has emerged as a significant, and frequently underestimated, trigger for melasma. Unlike UV radiation, standard sunscreens with only UV filters do little to block it.

For help choosing the right formulation, our comparison of Physical vs Chemical Sunscreen Pros and Cons breaks down which type offers better visible-light protection.

A randomized, investigator-blinded study comparing sunscreen formulations found that a visible-light-protective tinted sunscreen containing iron oxides significantly outperformed an equivalent untinted sunscreen in preventing melasma relapse during summer months, even though both products offered comparable UV protection.

This finding has real implications beyond outdoor sun exposure. Cleveland Clinic‘s patient education materials specifically list LED light from televisions, laptops, cell phones, and tablets among potential melasma aggravators, since these devices emit light within the visible spectrum. While screen-based light exposure is far less intense than direct sunlight, for people who spend hours in front of screens daily, it’s a reasonable factor to account for, especially alongside other triggers.

Heat and Infrared Radiation: The Trigger Most People Miss

Heat is frequently overlooked in melasma management, yet a growing body of research supports its role. A 2024 treatment review noted that melasma can be aggravated by heat exposure both at work and at home, and identifying and reducing known heat-related triggers is recommended as part of comprehensive management. The proposed mechanism involves infrared radiation and localized skin temperature increases contributing to inflammatory signaling that, in turn, stimulates melanocyte activity, independent of any UV or visible light exposure.

Everyday Habits That Quietly Worsen Melasma (Saunas, Cooking Over Stoves, Hot Yoga)

Given the role of heat, several common habits deserve a second look for anyone managing melasma: standing over a hot stove while cooking, regular sauna or steam room use, hot yoga, and even long, hot showers directed at the face. None of these need to be eliminated, but being mindful of frequency and, where practical, protecting the face from direct heat exposure is a reasonable, low-cost addition to a management plan.

Can Laptop or Phone Light Really Make Melasma Worse?

Based on current evidence, screen-based visible light is a plausible contributing factor, but it’s a minor one compared to direct sun exposure. The more actionable takeaway isn’t to avoid screens, but to ensure your daily sunscreen contains iron oxides, which protect against visible light broadly, whether the source is the sun or a device.

Treatment & Management Framework — Topicals, Procedures, and Daily Care

There’s no single treatment that resolves melasma permanently for every patient. What the evidence supports is a layered, consistent approach, and photoprotection sits at the foundation of all of it.

First-Line Topicals: Hydroquinone, Tretinoin, and Triple-Combination Cream

Hydroquinone remains one of the most extensively studied treatments for melasma. It works by inhibiting tyrosinase, the enzyme responsible for melanin production. According to the American Academy of Dermatology, hydroquinone is a common melasma treatment applied to the skin to help even out skin tone, and it’s no longer available in over-the-counter formulations and is now prescription-only.

What a Supervised Hydroquinone Course Actually Looks Like

Hydroquinone doesn’t work on a fast timeline, and knowing that upfront prevents both premature discouragement and overuse. Visible lightening from a 2–4% hydroquinone regimen typically doesn’t appear until 5 to 7 weeks into consistent use, and a full supervised course generally lasts anywhere from three months to a year (Draelos, Dermatologic Therapy, 2007).

Because higher-phototype skin carries a greater risk of complications, dermatologists typically schedule closer monitoring for these patients — roughly every three months for Fitzpatrick types V and VI, versus every six months for lighter skin types. In practice, this means “no visible change after two weeks” isn’t a sign hydroquinone has failed — it’s usually still too early to tell.

Tretinoin, a topical retinoid, is often paired with a mild corticosteroid to reduce inflammation and improve tolerability. The AAD notes that a combination of tretinoin and a mild corticosteroid can help even out skin tone, and when hydroquinone is added to that mix, it becomes what’s known as triple-combination cream, generally regarded by dermatologists as one of the most effective topical regimens available, though it requires medical supervision due to the potency of its ingredients and the risk of irritation or, with long-term hydroquinone overuse, a rare condition called exogenous ochronosis.

Not All Triple-Combination Creams Are Equal: Why the Steroid Matters

“Triple-combination cream” isn’t one fixed formula — it’s a category, and the steroid inside it changes the risk profile more than most patients realize. The FDA-cleared version pairs hydroquinone and tretinoin with fluocinolone acetonide, a mild fluorinated steroid. But in many markets, a mometasone furoate-based version became widely available and widely overused, often without a prescription.

The distinction isn’t academic. A retrospective study of 60 patients who used a mometasone-based triple combination for at least three weeks found that most had continued well past the recommended duration, and roughly a third rated their melasma as worse by the time they filled out the study questionnaire, largely due to rebound pigmentation after stopping.

A separate case series described patients developing skin thinning, persistent redness, and visible blood vessels within weeks of applying a mometasone-based combination, with melasma clearing temporarily and then relapsing.

The practical takeaway: if a triple-combination cream is part of your plan, it’s worth asking which steroid it contains. Formulas built around a milder fluorinated steroid are generally intended for short, defined courses — typically 4 to 8 weeks — followed by either a break or a switch to a gentler maintenance ingredient, not indefinite daily use.

Non-Hydroquinone Options: Azelaic Acid, Kojic Acid, and Niacinamide

For patients who can’t tolerate hydroquinone, are pregnant or breastfeeding, or are in a maintenance phase after active treatment, several gentler alternatives are commonly recommended. Azelaic acid inhibits tyrosinase activity with a favorable safety profile and doubles as an anti-inflammatory. Kojic acid works similarly, though it can be more irritating for sensitive skin at higher concentrations. Niacinamide doesn’t directly inhibit melanin production the way the others do; instead, it interferes with the transfer of pigment from melanocytes to surrounding skin cells, making it a useful, low-irritation addition to a maintenance routine.

For a deeper dive into this ingredient’s evidence and usage, read our full Azelaic Acid for Hyperpigmentation guide.

A less commonly discussed alternative is dioic acid, a dicarboxylic acid related to azelaic acid. In a 12-week comparative study of 96 women with melasma, 1% dioic acid cream performed comparably to 2% hydroquinone cream in reducing MASI scores, with one meaningful difference: patients using hydroquinone reported more itching than those using dioic acid. It’s not as extensively studied as azelaic acid or hydroquinone, but the existing data makes it a reasonable option to discuss with a dermatologist for patients who tolerate hydroquinone poorly.

Oral and Topical Tranexamic Acid — What the Evidence Says

Tranexamic acid has become one of the more closely studied melasma treatments in the past decade, largely because of its ability to target the vascular component discussed earlier in this guide, in addition to reducing pigment production.

The AAD states that tranexamic acid, whether applied topically or taken orally, has been shown in studies to decrease melasma patches when other treatments haven’t worked, and when prescribed as a pill, it’s typically taken twice daily.

Oral tranexamic acid isn’t appropriate for everyone. Because it affects blood clotting pathways, physicians will typically review a patient’s personal and family history of blood clots before prescribing it. This is a conversation to have directly with a board-certified dermatologist, not a treatment to source independently.

In-Office Procedures: Chemical Peels, Microneedling, and Laser Caution

Chemical peels using ingredients like glycolic, mandelic, or salicylic acid can help address more superficial, epidermal pigmentation and are often used as a complementary step alongside topical treatment. Microneedling, sometimes combined with topical tranexamic acid or vitamin C delivered directly into the skin, has shown promising results in newer research, including studies comparing intralesional treatments in patients with skin of color.

Laser treatment deserves a note of caution. While certain laser technologies can improve melasma, lasers also carry a real risk of worsening pigmentation, particularly in medium-to-deep skin tones, if the wrong device or settings are used. This is a procedure that should only be performed by a dermatologist experienced specifically in treating melasma in your skin type, not a general aesthetics provider.

What Peels and Laser Sessions Actually Involve

“Peels can help” is true but vague enough to set the wrong expectations. In practice, a superficial glycolic acid peel for melasma is generally left on for just 3 to 5 minutes per session, repeated every 2 to 3 weeks, with results building gradually across several sessions rather than appearing after one (Sarkar, Bansal & Garg, Journal of Cutaneous and Aesthetic Surgery, 2012).

Medium-depth peels using higher-strength trichloroacetic acid work faster but carry a meaningfully higher risk of scarring and prolonged discoloration in medium-to-deep skin tones, which is why they’re used cautiously, if at all, in this population.

Laser protocols follow a similarly specific structure. Where low-fluence Q-switched Nd: YAG laser toning is used, it’s typically delivered weekly, over roughly five sessions, with the treatment endpoint being mild redness rather than visible whitening — overly aggressive settings are what tend to trigger the post-inflammatory pigmentation this population is already prone to.

Adding intense pulsed light to laser toning has been shown to clear mixed-type melasma faster than laser toning alone, but a controlled trial of the combination still found recurrence “inevitable” after treatment stopped — one more reason lasers stay a last resort rather than a first move.

The Non-Negotiable: Tinted, Iron-Oxide Sunscreen and Daily Photoprotection

If this guide has one takeaway, it’s this: no topical treatment or procedure will produce lasting results without strict, daily photoprotection. Because standard sunscreens don’t block visible light, dermatologists increasingly recommend tinted, iron-oxide-containing formulations specifically for melasma patients.

A treatment review reinforces this, recommending a broad-spectrum sunscreen with SPF 50 or higher that shields against UVA, UVB, and visible light, preferably containing iron oxides, reapplied throughout the day as the cornerstone of long-term maintenance therapy, alongside physical barriers like broad-brimmed hats.

Not sure which formula suits your skin? See our picks for Best Sunscreen Ingredients for Sensitive Skin.

Camouflage Isn’t a Cop-Out

One point that’s easy to overlook: concealing makeup isn’t a treatment failure or a workaround to feel embarrassed about. Dermatology guidance on melasma management specifically recommends offering camouflage makeup as a concurrent option at any stage of treatment, not just as a last resort when nothing else works. Used alongside — not instead of — a real treatment plan, it’s a legitimate way to manage how melasma affects daily life while the actual pigment-correcting work happens on its own slower timeline.

Building a Sustainable Long-Term Maintenance Routine

After active treatment reduces visible pigmentation, the work isn’t over. Maintenance typically involves stepping down from potent actives like hydroquinone to gentler, sustainable options such as azelaic acid and niacinamide, while keeping daily tinted sunscreen non-negotiable year-round, not just in summer. Patients who stop all treatment and sun protection once their skin clears often see melasma return within months.

For a step-by-step framework, check out our full Skincare Routine for Hyperpigmentation guide.

Putting It Together: A Sample Daily Structure

All the ingredients covered above only work as a system if they’re sequenced sensibly. A reasonable daily structure looks like this:

Morning: gentle cleanse, then a maintenance active (azelaic acid or niacinamide, or a supervised hydroquinone course if you’re in an active treatment phase rather than maintenance), then a barrier-supporting moisturizer, then a tinted, broad-spectrum SPF 50 sunscreen with iron oxides as the final, non-negotiable step. Reapply every two hours during real sun exposure.

Evening: gentle cleanse, then one active treatment step — not several stacked together. Tretinoin or a retinoid on some nights; a gentler resurfacing step (like a low-strength chemical exfoliant) on others; a barrier-repair moisturizer to close out the routine.

The sequencing matters as much as the ingredients. Stacking a strong acid and a retinoid on the same night, or combining active treatment with aggressive at-home exfoliation, pushes skin toward the irritation and friction that can trigger fresh post-inflammatory pigment — undoing the exact progress the routine is meant to produce. If a night feels like “more is better,” it’s usually the night to hold back instead.

How Long Does It Take to See Results From Melasma Treatment?

Most evidence-based regimens require patience. The AAD notes that following a treatment plan involving tranexamic acid, triple-combination cream, and sun protection typically takes between 3 and 12 months to show results. Expecting visible improvement within a few weeks sets up most patients for disappointment and can lead to overuse of harsh actives in an attempt to speed things up, which often backfires.

How Progress Actually Gets Measured — and Why Some Cases Take Longer

Most of the clinical trials behind the treatments in this guide didn’t rely on patients simply saying their skin “looked better.” They used the Melasma Area and Severity Index, or MASI, a standardized scoring system that grades the area affected, the darkness of the pigment, and how evenly it’s distributed across defined regions of the face. If you’re working with a dermatologist, ask whether they’re tracking your MASI score or comparable standardized photography — it gives you an objective benchmark rather than a subjective impression, which matters for a condition that fades and returns.

It’s also worth knowing upfront that some cases are simply slower to respond. A multi-author dermatology consensus review identified several factors associated with a harder-to-treat course: darker phototypes (Fitzpatrick IV–VI), a strong family history of melasma, melasma present for two or more years before starting a consistent treatment plan, a history of self-treating with steroid-containing creams, visible signs of ochronosis, and mixed epidermal-dermal melasma rather than the epidermal type alone.

None of these make melasma untreatable — they just mean a longer runway and more emphasis on maintenance is realistic, not a sign the treatment has failed.

Is It Safe to Use Hydroquinone Long-Term?

Hydroquinone is effective, but it’s meant for supervised, cyclical use rather than indefinite daily application. Prolonged, unsupervised use has been linked to a rare but serious condition called exogenous ochronosis, which causes a blue-black discoloration. Dermatologists typically prescribe it in defined courses, often a few months on followed by a break or a switch to a maintenance ingredient.

Why This Isn’t Just a Cosmetic Concern

It’s worth naming plainly that melasma’s impact isn’t only skin-deep. In a study using a validated melasma-specific quality-of-life questionnaire, 94% of patients said they felt bothered by their skin’s appearance, nearly two-thirds reported frustration and embarrassment, and over half described feeling depressed about their condition. None of that makes the biology any less real or the timeline any less genuine — but it’s a legitimate part of why melasma is worth treating seriously, and why “it’s just pigment” undersells what patients are actually dealing with.

Conclusion: Complete Science-Backed Guide to Melasma

Melasma is rarely the result of one single cause. Genetics set the stage, hormonal activity, particularly estrogen and progesterone, pulls the trigger, and ongoing exposure to UV rays, visible light, and heat keeps the cycle going long after it first appears. Understanding that layered biology is what separates a frustrating, one-off skincare purchase from an actual, sustainable management plan.

Melasma is manageable for most people, even if it isn’t always fully “curable” in the way an isolated blemish is. The patients who see the most consistent, lasting improvement are the ones who treat sun and visible-light protection as daily, year-round non-negotiables, work with a board-certified dermatologist to choose the right combination of topical and, when appropriate, procedural treatments, and commit to a realistic timeline of months, not weeks.

If you’re dealing with melasma that isn’t responding to over-the-counter products, the most valuable next step isn’t another serum. It’s a conversation with a board-certified dermatologist who can evaluate your specific pattern, rule out contributing factors like thyroid dysfunction, and build a maintenance routine designed to actually hold.

FAQ: Complete Science-Backed Guide to Melasma

Which hormone is linked to melasma?

Estrogen and progesterone are the hormones most strongly linked to melasma, which is why it commonly develops during pregnancy, with hormonal birth control, or during hormone replacement therapy. Research also shows progesterone receptor activity is notably elevated in melasma-affected skin, suggesting it may play an even more direct role than previously believed.

Can low estrogen trigger melasma?

Current evidence points to elevated estrogen, as seen during pregnancy or with estrogen-containing birth control, as the more established trigger, not low estrogen. That said, hormonal fluctuation in general, including shifts during perimenopause, can influence melanocyte activity, so both rising and imbalanced hormone levels may contribute in individual cases.

What vitamin deficiency causes melasma?

No specific vitamin deficiency has been scientifically proven to cause melasma directly. Some research suggests low antioxidant status may worsen oxidative stress in skin, but hormones, sun exposure, visible light, and genetic predisposition remain the primary, well-established drivers identified in current dermatology research.

How to stop melasma from spreading?

Strict, daily photoprotection is the most effective way to limit melasma from spreading further. This means applying a tinted, broad-spectrum sunscreen containing iron oxides, reapplying every two hours during sun exposure, using physical barriers like wide-brimmed hats, and identifying and reducing personal triggers such as heat exposure where possible.

How to naturally remove melasma?

There is no proven, fully natural cure for melasma. However, consistent sun and visible-light avoidance, gentle brightening ingredients like azelaic acid and niacinamide, and addressing underlying hormonal or thyroid imbalances with a physician can meaningfully reduce pigmentation over time, even though complete removal usually still requires dermatologist-guided treatment.

What’s the best cure for melasma?

There isn’t one universal cure, since melasma is chronic and prone to recurrence. The most effective evidence-based approach combines daily tinted, iron-oxide sunscreen, a dermatologist-prescribed topical such as triple-combination cream or tranexamic acid, and a long-term maintenance routine rather than a single fixed treatment.

Can you make melasma go away?

Yes, melasma can fade significantly or become nearly undetectable with proper, consistent treatment. Most evidence-based regimens take between 3 and 12 months to show meaningful results, and ongoing maintenance is typically needed afterward to prevent recurrence, especially following sun exposure or hormonal changes.

Will melasma go away if I balance my hormones?

Addressing underlying hormonal issues, such as thyroid dysfunction, may help reduce melasma severity in some patients, but it’s rarely sufficient as a standalone solution. Most dermatologists recommend pairing any hormonal management with topical treatment and strict daily sun and visible-light protection for meaningful, lasting improvement.